Praxis Precision Medicines (PRAX) Operating Expenses (2019 - 2026)

Praxis Precision Medicines' Operating Expenses history runs 8 years deep, the most recent figure standing at $105.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 41.66% year-over-year to $105.9 million; the TTM figure through Mar 2026 stood at $357.3 million (up 48.19% YoY), while the FY2025 annual figure was $326.2 million, up 56.29% from the prior year.
• Operating Expenses was $105.9 million for Q1 2026 at Praxis Precision Medicines, up from $97.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $105.9 million in Q1 2026 to a low of $26.0 million in Q3 2023.
• Historically, Operating Expenses has averaged $57.9 million across 5 years, with a median of $57.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses slumped 43.68% in 2023, then surged 152.18% in 2024.
• A 5-year view of Operating Expenses shows it stood at $41.5 million in 2022, then sank by 31.68% to $28.3 million in 2023, then soared by 152.18% to $71.4 million in 2024, then surged by 35.88% to $97.0 million in 2025, then grew by 9.08% to $105.9 million in 2026.
• The last three Operating Expenses figures came in at $105.9 million (Q1 2026), $97.0 million (Q4 2025), and $78.4 million (Q3 2025), per Business Quant data.